Role of GSK‐3β activation and α7 nAChRs in Aβ1–42‐induced tau phosphorylation in PC12 cells
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
β‐amyloid peptide 1–42 (Aβ 1–42) and hyperphosphorylated tau are associated with neurodegeneration in Alzheimer’s disease. Emerging evidence indicates that Aβ 1–42 can potentiate hyperphosphorylation of tau in cell lines and in transgenic mice, but the underlying mechanism(s) remains unclear. In this study, Aβ 1–42‐induced tau phosphorylation was investigated in differentiated PC12 cells. Treatment of cells with Aβ 1–42 increased phosphorylation of tau at serine‐202 as detected by AT8 antibody. This Aβ 1–42‐induced tau phosphorylation paralleled phosphorylation of glycogen synthase kinase‐3β (GSK‐3β) at tyrosine‐216 (GSK‐3β‐pY216), which was partially inhibited by the GSK‐3β inhibitor, CHIR98023. Aβ 1–42‐induced tau phosphorylation and increase in GSK‐3β‐pY216 phosphorylation were also partially attenuated by α7 nicotinic acetylcholine receptor (α7 nAChR) selective ligands including agonist A‐582941 and antagonists methyllycaconitine and α‐bungarotoxin. The α7 nAChR agonist and the GSK‐3β inhibitor had no additive effect. These observations suggest that α7 nAChR modulation can influence Aβ 1–42‐induced tau phosphorylation, possibly involving GSK‐3β. This study provides evidence of nAChR mechanisms underlying Aβ 1–42 toxicity and tau phosphorylation, which, if translated in vivo, could provide additional basis for the utility of α7 nAChR ligands in the treatment of Alzheimer’s disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769 · cited 1×
“Such Ab1–42 oligomer species could include Ab1–42-derived diffusible ligands (Lambert et al. 1998), Ab1–42 globulomer (Barghorn et al. 2005), or the 56-kDa Ab* (Lesne et al. 2006).”
BackgroundRetractedEnhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP
Lewis, J., Dickson, D. W., Lin, W.-L., Chisholm, L., Corral, A., Jones, G., Yen, S.-H., Sahara, N., Skipper, L., Yager, D., et al. (2001) · Science · doi:10.1126/science.1058189 · Cited by 1,611 · cited 2×
“Higher levels of NFTs were observed in the double transgenic (tauP301L and APPsw) mutant mice (Lewis et al. 2001) and in aged 3xTgAD mice with both amyloid plaques and NFTs where improved cognitive function was observed only when both Ab1–42 and tau levels, but not Ab1–42 alone, were reduced after…”
BackgroundDeciphering the Molecular Basis of Memory Failure in Alzheimer's Disease
Walsh, D. M., & Selkoe, D. J. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.010 · Cited by 1,207
Tau is essential to β-amyloid-induced neurotoxicity
Rapoport, M., Dawson, H. N., Binder, L. I., Vitek, M. P., & Ferreira, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092136199 · Cited by 807
β-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding
Busciglio, J., Lorenzo, A., Yeh, J., & Yankner, B. A. (1995) · Neuron · doi:10.1016/0896-6273(95)90232-5 · Cited by 595
Barghorn, S., Nimmrich, V., Striebinger, A., Krantz, C., Keller, P., Janson, B., Bahr, M., Schmidt, M., Bitner, R. S., Harlan, J., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03407.x · Cited by 559
Zheng, W.-H., Bastianetto, S., Mennicken, F., Ma, W., & Kar, S. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00404-9 · Cited by 321
Kimura, R., Kamino, K., Yamamoto, M., Nuripa, A., Kida, T., Kazui, H., Hashimoto, R., Tanaka, T., Kudo, T., Yamagata, H., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddl437 · Cited by 281 · cited 1×
“…tau phosphorylation also paralleled activation of GSK-3b (Zheng et al. 2002; Esposito et al. 2006), extracellular signal-regulated kinase (Zheng et al. 2002; Wang et al. 2003), c-Jun N-terminal kinase JNK-1 (Wang et al. 2003), and dual-specificity tyrosine-regulated kinase (Kimura et al. 2007).”
BackgroundOddo, S., Caccamo, A., Green, K. N., Liang, K., Tran, L., Chen, Y., Leslie, F. M., & LaFerla, F. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408500102 · Cited by 211 · cited 1×
“It should also be noted that nicotine has been shown to increase tau phosphorylation in neuron-like cell cultures (Hellstrom-Lindahl et al. 2000; Wang et al. 2003) and in the 3xTg-AD mice (Oddo et al. 2005).”
Background
Cited by
The cholinergic system in aging and neuronal degeneration
Schliebs, R., & Arendt, T. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.11.058 · Cited by 1,047
Buckingham, S. D., Jones, A. K., Brown, L. A., & Sattelle, D. B. (2009) · Pharmacological Reviews · doi:10.1124/pr.108.000562 · Cited by 308
Increasing Cu bioavailability inhibits Aβ oligomers and tau phosphorylation
Crouch, P. J., Hung, L. W., Adlard, P. A., Cortes, M., Lal, V., Filiz, G., Perez, K. A., Nurjono, M., Caragounis, A., Du, T., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809057106 · Cited by 278
Eckert, A., Schmitt, K., & Götz, J. (2011) · Alzheimer's Research & Therapy · doi:10.1186/alzrt74 · Cited by 177
Kurata, T., Miyazaki, K., Kozuki, M., Panin, V.-L., Morimoto, N., Ohta, Y., Nagai, M., Ikeda, Y., Matsuura, T., & Abe, K. (2011) · Brain Research · doi:10.1016/j.brainres.2010.11.067 · Cited by 98
Metadata
- Authors
- Hu, M., Waring, J. F., Gopalakrishnan, M., & Li, J.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2008-07-15
- Volume
- 106
- Issue
- 3
- Pages
- 1371-1377
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1972995966
- Cited by
- 67
- References
- 9
- FWCI
- 4.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Role of GSK‐3β activation and α7 nAChRs in Aβ1–42‐induced tau phosphorylation in PC12 cells. https://app.cochat.ai/papers/10.1111/j.1471-4159.2008.05483.x
- The paper
- Hu, M., Waring, J. F., Gopalakrishnan, M., & Li, J. (2008). Role of GSK‐3β activation and α7 nAChRs in Aβ1–42‐induced tau phosphorylation in PC12 cells. Journal of Neurochemistry. https://doi.org/10.1111/j.1471-4159.2008.05483.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.